Factset Research Systems Inc: Form 10-Q for the period ended Feb 28, 2023
Filed with the SEC on Apr 3, 2023 and accepted by EDGAR at Apr 3, 2023, 07:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-02-28. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-12-01 to 2023-02-28 | $515.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-09-01 to 2023-02-28 | $1.02bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-12-01 to 2023-02-28 | $240.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-09-01 to 2023-02-28 | $467.8m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2022-12-01 to 2023-02-28 | $104.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-09-01 to 2023-02-28 | $210.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-12-01 to 2023-02-28 | $169.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-09-01 to 2023-02-28 | $341.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-12-01 to 2023-02-28 | $25.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-09-01 to 2023-02-28 | $46.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-12-01 to 2023-02-28 | $131.6m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-09-01 to 2023-02-28 | $268.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-12-01 to 2023-02-28 | $3.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-09-01 to 2023-02-28 | $6.89 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-12-01 to 2023-02-28 | $3.44 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-09-01 to 2023-02-28 | $7.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-12-01 to 2023-02-28 | 38,981,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-09-01 to 2023-02-28 | 38,947,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-09-01 to 2023-02-28 | $271.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-12-01 to 2023-02-28 | $17.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2022-09-01 to 2023-02-28 | $35.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-09-01 to 2023-02-28 | $67.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2022-09-01 to 2023-02-28 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-02-28 | $445.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-02-28 | $858.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-02-28 | $4.00bn | us-gaap:Assets |
| Current liabilities | At period end2023-02-28 | $410.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-02-28 | $2.39bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-02-28 | $1.74bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2023-02-28 | $1.61bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001013237-23-000044. Last ingested by Listed: Oct 26, 2026, 08:25 ET. Listed shows no prices and gives no investment advice.